APO Research
Talk to an analyst

APO RESEARCH · REPORT

Postbiotics CDMO Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Postbiotics CDMO Service Market Analysis and Forecast 2026-2032

5 June 2026226 pages

Choose your research edition.

Industry ResearchPostbiotics CDMO Service Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Postbiotics CDMO Service Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Postbiotics CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Postbiotics CDMO Service Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Postbiotics CDMO Service Market Analysis and Forecast 2026-2032226 pages · $4,950 USD

Market perspective

The global Postbiotics CDMO Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Postbiotics CDMO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Postbiotics CDMO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Postbiotics CDMO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Postbiotics CDMO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Postbiotics CDMO Service include ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma and Sacco System, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Postbiotics CDMO Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Postbiotics CDMO Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Postbiotics CDMO Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Postbiotics CDMO Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Postbiotics CDMO Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Postbiotics CDMO Service revenue, projected growth trends, production technology, application and end-user industry.

Postbiotics CDMO Service Segment by Company

ILDONG Bioscience Co., Ltd.

Bioprox Healthcare

Exden

JuneYao Group (BioGrowing)

dsm-firmenich (Adare Pharma Solutions)

Sirio Pharma

Sacco System

Postbiotics CDMO Service Segment by Type

Oral Dosage Forms (Capsules And Tablets)

Powders and Granules

Liquid Preparations

Postbiotics CDMO Service Segment by Application

Medicines and Health Products

Food

Pet Food

Cosmetics

Postbiotics CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Postbiotics CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Postbiotics CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Postbiotics CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Postbiotics CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Postbiotics CDMO Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Postbiotics CDMO Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Postbiotics CDMO Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Dosage Forms (Capsules And Tablets) Major Player Table 3. Powders and Granules Major Player Table 4. Liquid Preparations Major Player Table 5. Global Postbiotics CDMO Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Medicines and Health Products Major Player Table 7. Food Major Player Table 8. Pet Food Major Player Table 9. Cosmetics Major Player Table 10. Postbiotics CDMO Service Industry Trends Table 11. Postbiotics CDMO Service Industry Drivers Table 12. Postbiotics CDMO Service Industry Opportunities and Challenges Table 13. Postbiotics CDMO Service Industry Restraints Table 14. Global Postbiotics CDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Postbiotics CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Postbiotics CDMO Service Market Share by Region (2021-2026) Table 17. Global Postbiotics CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Postbiotics CDMO Service Market Share by Region (2027-2032) Table 19. Global Postbiotics CDMO Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Postbiotics CDMO Service Revenue Market Share by Players (2021-2026) Table 21. Global Postbiotics CDMO Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Postbiotics CDMO Service Key Players Headquarters & Area Served Table 23. Global Postbiotics CDMO Service Players, Product Type & Application Table 24. Global Postbiotics CDMO Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Postbiotics CDMO Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Postbiotics CDMO Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Postbiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Postbiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Postbiotics CDMO Service Revenue Market Share by Type (2021-2026) Table 31. Global Postbiotics CDMO Service Revenue Market Share by Type (2027-2032) Table 32. Global Postbiotics CDMO Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Postbiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Postbiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Postbiotics CDMO Service Revenue Market Share by Application (2021-2026) Table 36. Global Postbiotics CDMO Service Revenue Market Share by Application (2027-2032) Table 37. ILDONG Bioscience Co., Ltd. Company Information Table 38. ILDONG Bioscience Co., Ltd. Business Overview Table 39. ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Product Portfolio Table 41. ILDONG Bioscience Co., Ltd. Recent Development Table 42. Bioprox Healthcare Company Information Table 43. Bioprox Healthcare Business Overview Table 44. Bioprox Healthcare Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Bioprox Healthcare Postbiotics CDMO Service Product Portfolio Table 46. Bioprox Healthcare Recent Development Table 47. Exden Company Information Table 48. Exden Business Overview Table 49. Exden Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Exden Postbiotics CDMO Service Product Portfolio Table 51. Exden Recent Development Table 52. JuneYao Group (BioGrowing) Company Information Table 53. JuneYao Group (BioGrowing) Business Overview Table 54. JuneYao Group (BioGrowing) Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. JuneYao Group (BioGrowing) Postbiotics CDMO Service Product Portfolio Table 56. JuneYao Group (BioGrowing) Recent Development Table 57. dsm-firmenich (Adare Pharma Solutions) Company Information Table 58. dsm-firmenich (Adare Pharma Solutions) Business Overview Table 59. dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Product Portfolio Table 61. dsm-firmenich (Adare Pharma Solutions) Recent Development Table 62. Sirio Pharma Company Information Table 63. Sirio Pharma Business Overview Table 64. Sirio Pharma Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Sirio Pharma Postbiotics CDMO Service Product Portfolio Table 66. Sirio Pharma Recent Development Table 67. Sacco System Company Information Table 68. Sacco System Business Overview Table 69. Sacco System Postbiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Sacco System Postbiotics CDMO Service Product Portfolio Table 71. Sacco System Recent Development Table 72. North America Postbiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Postbiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Postbiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Postbiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Postbiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Postbiotics CDMO Service Revenue by Country (2021-2026) & (US$ Million) Table 78. North America Postbiotics CDMO Service Revenue by Country (US$ Million) & (2027-2032) Table 79. Europe Postbiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 80. Europe Postbiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 81. Europe Postbiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 82. Europe Postbiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 83. Europe Postbiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Europe Postbiotics CDMO Service Revenue by Country (2021-2026) & (US$ Million) Table 85. Europe Postbiotics CDMO Service Revenue by Country (US$ Million) & (2027-2032) Table 86. China Postbiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 87. China Postbiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 88. China Postbiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 89. China Postbiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 90. Asia Postbiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 91. Asia Postbiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 92. Asia Postbiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 93. Asia Postbiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Postbiotics CDMO Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Asia Postbiotics CDMO Service Revenue by Region (US$ Million) & (2021-2026) Table 96. Asia Postbiotics CDMO Service Revenue by Region (US$ Million) & (2027-2032) Table 97. SAMEA Postbiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 98. SAMEA Postbiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 99. SAMEA Postbiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 100. SAMEA Postbiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 101. SAMEA Postbiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. SAMEA Postbiotics CDMO Service Revenue by Country (2021-2026) & (US$ Million) Table 103. SAMEA Postbiotics CDMO Service Revenue by Country (US$ Million) & (2027-2032) Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Postbiotics CDMO Service Image Figure 2. Global Postbiotics CDMO Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Postbiotics CDMO Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Dosage Forms (Capsules And Tablets) Image Figure 5. Powders and Granules Image Figure 6. Liquid Preparations Image Figure 7. Global Postbiotics CDMO Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Postbiotics CDMO Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Medicines and Health Products Image Figure 10. Food Image Figure 11. Pet Food Image Figure 12. Cosmetics Image Figure 13. Global Postbiotics CDMO Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Postbiotics CDMO Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Postbiotics CDMO Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Postbiotics CDMO Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Postbiotics CDMO Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Postbiotics CDMO Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Postbiotics CDMO Service Revenue Market Share by Type (2021-2032) Figure 21. Global Postbiotics CDMO Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Postbiotics CDMO Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Postbiotics CDMO Service Revenue Market Share by Application (2021-2032) Figure 24. North America Postbiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Postbiotics CDMO Service Revenue Share by Type (2021-2032) Figure 26. North America Postbiotics CDMO Service Revenue Share by Application (2021-2032) Figure 27. North America Postbiotics CDMO Service Revenue Share by Country (2021-2032) Figure 28. United States Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Postbiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Postbiotics CDMO Service Revenue Share by Type (2021-2032) Figure 33. Europe Postbiotics CDMO Service Revenue Share by Application (2021-2032) Figure 34. Europe Postbiotics CDMO Service Revenue Share by Country (2021-2032) Figure 35. Germany Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Postbiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Postbiotics CDMO Service Revenue Share by Type (2021-2032) Figure 45. China Postbiotics CDMO Service Revenue Share by Application (2021-2032) Figure 46. Asia Postbiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Postbiotics CDMO Service Revenue Share by Type (2021-2032) Figure 48. Asia Postbiotics CDMO Service Revenue Share by Application (2021-2032) Figure 49. Asia Postbiotics CDMO Service Revenue Share by Region (2021-2032) Figure 50. Japan Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Postbiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Postbiotics CDMO Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Postbiotics CDMO Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Postbiotics CDMO Service Revenue Share by Country (2021-2032) Figure 60. Brazil Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Postbiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Dosage Forms (Capsules And Tablets)
  • Powders and Granules
  • Liquid Preparations
Applications
  • Medicines and Health Products
  • Food
  • Pet Food
  • Cosmetics
Companies covered
  • ILDONG Bioscience Co., Ltd.
  • Bioprox Healthcare
  • Exden
  • JuneYao Group (BioGrowing)
  • dsm-firmenich (Adare Pharma Solutions)
  • Sirio Pharma
  • Sacco System

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Postbiotics CDMO Service Market by Type
  3. 1.2.1 Global Postbiotics CDMO Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Dosage Forms (Capsules And Tablets)
  5. 1.2.3 Powders and Granules
  6. 1.2.4 Liquid Preparations
  7. 1.3 Postbiotics CDMO Service Market by Application
  8. 1.3.1 Global Postbiotics CDMO Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Medicines and Health Products
  10. 1.3.3 Food
  11. 1.3.4 Pet Food
  12. 1.3.5 Cosmetics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Postbiotics CDMO Service Market Dynamics
  1. 2.1 Postbiotics CDMO Service Industry Trends
  2. 2.2 Postbiotics CDMO Service Industry Drivers
  3. 2.3 Postbiotics CDMO Service Industry Opportunities and Challenges
  4. 2.4 Postbiotics CDMO Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Postbiotics CDMO Service Market Perspective (2021-2032)
  2. 3.2 Global Postbiotics CDMO Service Growth Trends by Region
  3. 3.2.1 Global Postbiotics CDMO Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Postbiotics CDMO Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Postbiotics CDMO Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Postbiotics CDMO Service Revenue by Players
  2. 4.1.1 Global Postbiotics CDMO Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Postbiotics CDMO Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Postbiotics CDMO Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Postbiotics CDMO Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Postbiotics CDMO Service Key Players Headquarters & Area Served
  7. 4.4 Global Postbiotics CDMO Service Players, Product Type & Application
  8. 4.5 Global Postbiotics CDMO Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Postbiotics CDMO Service Market CR5 and HHI
  11. 4.6.3 2025 Postbiotics CDMO Service Tier 1, Tier 2, and Tier 3
5 Postbiotics CDMO Service Market Size by Type
  1. 5.1 Global Postbiotics CDMO Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Postbiotics CDMO Service Revenue by Type (2021-2032)
  3. 5.3 Global Postbiotics CDMO Service Revenue Market Share by Type (2021-2032)
6 Postbiotics CDMO Service Market Size by Application
  1. 6.1 Global Postbiotics CDMO Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Postbiotics CDMO Service Revenue by Application (2021-2032)
  3. 6.3 Global Postbiotics CDMO Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ILDONG Bioscience Co., Ltd.
  2. 7.1.1 ILDONG Bioscience Co., Ltd. Company Information
  3. 7.1.2 ILDONG Bioscience Co., Ltd. Business Overview
  4. 7.1.3 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Product Portfolio
  6. 7.1.5 ILDONG Bioscience Co., Ltd. Recent Developments
  7. 7.2 Bioprox Healthcare
  8. 7.2.1 Bioprox Healthcare Company Information
  9. 7.2.2 Bioprox Healthcare Business Overview
  10. 7.2.3 Bioprox Healthcare Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bioprox Healthcare Postbiotics CDMO Service Product Portfolio
  12. 7.2.5 Bioprox Healthcare Recent Developments
  13. 7.3 Exden
  14. 7.3.1 Exden Company Information
  15. 7.3.2 Exden Business Overview
  16. 7.3.3 Exden Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Exden Postbiotics CDMO Service Product Portfolio
  18. 7.3.5 Exden Recent Developments
  19. 7.4 JuneYao Group (BioGrowing)
  20. 7.4.1 JuneYao Group (BioGrowing) Company Information
  21. 7.4.2 JuneYao Group (BioGrowing) Business Overview
  22. 7.4.3 JuneYao Group (BioGrowing) Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 JuneYao Group (BioGrowing) Postbiotics CDMO Service Product Portfolio
  24. 7.4.5 JuneYao Group (BioGrowing) Recent Developments
  25. 7.5 dsm-firmenich (Adare Pharma Solutions)
  26. 7.5.1 dsm-firmenich (Adare Pharma Solutions) Company Information
  27. 7.5.2 dsm-firmenich (Adare Pharma Solutions) Business Overview
  28. 7.5.3 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Product Portfolio
  30. 7.5.5 dsm-firmenich (Adare Pharma Solutions) Recent Developments
  31. 7.6 Sirio Pharma
  32. 7.6.1 Sirio Pharma Company Information
  33. 7.6.2 Sirio Pharma Business Overview
  34. 7.6.3 Sirio Pharma Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sirio Pharma Postbiotics CDMO Service Product Portfolio
  36. 7.6.5 Sirio Pharma Recent Developments
  37. 7.7 Sacco System
  38. 7.7.1 Sacco System Company Information
  39. 7.7.2 Sacco System Business Overview
  40. 7.7.3 Sacco System Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sacco System Postbiotics CDMO Service Product Portfolio
  42. 7.7.5 Sacco System Recent Developments
8 North America
  1. 8.1 North America Postbiotics CDMO Service Revenue (2021-2032)
  2. 8.2 North America Postbiotics CDMO Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Postbiotics CDMO Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Postbiotics CDMO Service Revenue by Type (2027-2032)
  5. 8.3 North America Postbiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Postbiotics CDMO Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Postbiotics CDMO Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Postbiotics CDMO Service Revenue by Application (2027-2032)
  9. 8.5 North America Postbiotics CDMO Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Postbiotics CDMO Service Revenue by Country
  11. 8.6.1 North America Postbiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Postbiotics CDMO Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Postbiotics CDMO Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Postbiotics CDMO Service Revenue (2021-2032)
  2. 9.2 Europe Postbiotics CDMO Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Postbiotics CDMO Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Postbiotics CDMO Service Revenue by Type (2027-2032)
  5. 9.3 Europe Postbiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Postbiotics CDMO Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Postbiotics CDMO Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Postbiotics CDMO Service Revenue by Application (2027-2032)
  9. 9.5 Europe Postbiotics CDMO Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Postbiotics CDMO Service Revenue by Country
  11. 9.6.1 Europe Postbiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Postbiotics CDMO Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Postbiotics CDMO Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Postbiotics CDMO Service Revenue (2021-2032)
  2. 10.2 China Postbiotics CDMO Service Revenue by Type (2021-2032)
  3. 10.2.1 China Postbiotics CDMO Service Revenue by Type (2021-2026)
  4. 10.2.2 China Postbiotics CDMO Service Revenue by Type (2027-2032)
  5. 10.3 China Postbiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 10.4 China Postbiotics CDMO Service Revenue by Application (2021-2032)
  7. 10.4.1 China Postbiotics CDMO Service Revenue by Application (2021-2026)
  8. 10.4.2 China Postbiotics CDMO Service Revenue by Application (2027-2032)
  9. 10.5 China Postbiotics CDMO Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Postbiotics CDMO Service Revenue (2021-2032)
  2. 11.2 Asia Postbiotics CDMO Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Postbiotics CDMO Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Postbiotics CDMO Service Revenue by Type (2027-2032)
  5. 11.3 Asia Postbiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Postbiotics CDMO Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Postbiotics CDMO Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Postbiotics CDMO Service Revenue by Application (2027-2032)
  9. 11.5 Asia Postbiotics CDMO Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Postbiotics CDMO Service Revenue by Country
  11. 11.6.1 Asia Postbiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Postbiotics CDMO Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Postbiotics CDMO Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Postbiotics CDMO Service Revenue (2021-2032)
  2. 12.2 SAMEA Postbiotics CDMO Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Postbiotics CDMO Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Postbiotics CDMO Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Postbiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Postbiotics CDMO Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Postbiotics CDMO Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Postbiotics CDMO Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Postbiotics CDMO Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Postbiotics CDMO Service Revenue by Country
  11. 12.6.1 SAMEA Postbiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Postbiotics CDMO Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Postbiotics CDMO Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst